P00520
Gene name |
Abl1 (Abl) |
Protein name |
Tyrosine-protein kinase ABL1 |
Names |
Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine-protein kinase 1, Proto-oncogene c-Abl, p150 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:11350 |
EC number |
2.7.10.2: Protein-tyrosine kinases |
Protein Class |
TYROSINE-PROTEIN KINASE (PTHR24418) |

Descriptions
Abelson tyrosine kinase (Abl1) is a non-receptor tyrosine kinase that involved in many processes linked to cell growth and survival such as cytoskeleton remodeling, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Abl protein contains a CAP-SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity. Structural and biochemical studies revealed the multiple autoinhibitory mechanisms. The tyrosine kinase activity of Abl1 is increased by disrupting these autoinhibitory interactions, such as the N-terminal CAP domain mutation, the SH3 domain mutation, the SH2 domain mutations, and the SH2-TK linker-region double mutation. Also, Abl1 has an activation loop in which Tyr393 is the major site of phosphorylation.
Autoinhibitory domains (AIDs)
Target domain |
242-493 (Protein kinase domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
Structural analysis, Mutagenesis experiment |
Target domain |
242-493 (Protein kinase domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
Structural analysis, Mutagenesis experiment |
Target domain |
242-493 (Protein kinase domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
Structural analysis, Mutagenesis experiment |
Target domain |
242-493 (Protein kinase domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
Structural analysis, Mutagenesis experiment |
Accessory elements
380-404 (Activation loop from InterPro)
Target domain |
242-493 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Schindler T et al. (2000) "Structural mechanism for STI-571 inhibition of abelson tyrosine kinase", Science (New York, N.Y.), 289, 1938-42
- Colicelli J (2010) "ABL tyrosine kinases: evolution of function, regulation, and specificity", Science signaling, 3, re6
- Hantschel O et al. (2003) "A myristoyl/phosphotyrosine switch regulates c-Abl", Cell, 112, 845-57
- Walkenhorst J et al. (1996) "Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe", Oncogene, 12, 1513-20
- Pluk H et al. (2002) "Autoinhibition of c-Abl", Cell, 108, 247-59
- Woodring PJ et al. (2001) "Inhibition of c-Abl tyrosine kinase activity by filamentous actin", The Journal of biological chemistry, 276, 27104-10
- Nagar B et al. (2003) "Structural basis for the autoinhibition of c-Abl tyrosine kinase", Cell, 112, 859-71
Autoinhibited structure
Activated structure

25 structures for P00520
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1ABO | X-ray | 200 A | A/B | 61-121 | PDB |
1ABQ | X-ray | 280 A | A | 61-121 | PDB |
1FPU | X-ray | 240 A | A/B | 229-515 | PDB |
1IEP | X-ray | 210 A | A/B | 229-515 | PDB |
1M52 | X-ray | 260 A | A/B | 229-515 | PDB |
1OPJ | X-ray | 175 A | A/B | 229-515 | PDB |
1OPK | X-ray | 180 A | A | 27-515 | PDB |
2HZN | X-ray | 270 A | A | 229-515 | PDB |
2QOH | X-ray | 195 A | A/B | 229-515 | PDB |
2Z60 | X-ray | 195 A | A | 229-515 | PDB |
3DK3 | X-ray | 202 A | A/B | 233-514 | PDB |
3DK6 | X-ray | 202 A | A/B | 233-514 | PDB |
3DK7 | X-ray | 201 A | A/B | 233-505 | PDB |
3IK3 | X-ray | 190 A | A/B | 229-513 | PDB |
3K5V | X-ray | 174 A | A/B | 229-515 | PDB |
3KF4 | X-ray | 190 A | A/B | 229-515 | PDB |
3KFA | X-ray | 122 A | A/B | 229-515 | PDB |
3MS9 | X-ray | 180 A | A/B | 229-515 | PDB |
3MSS | X-ray | 195 A | A/B/C/D | 229-515 | PDB |
3OXZ | X-ray | 220 A | A | 229-511 | PDB |
3OY3 | X-ray | 195 A | A/B | 229-511 | PDB |
5IH2 | X-ray | 180 A | M/N | 757-765 | PDB |
6HD4 | X-ray | 203 A | A/B | 229-515 | PDB |
6HD6 | X-ray | 230 A | A/B | 229-515 | PDB |
AF-P00520-F1 | Predicted | AlphaFoldDB |
14 variants for P00520
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs222595528 | 583 | S>G | No | Ensembl | |
rs242663154 | 593 | R>K | No | Ensembl | |
rs254115523 | 595 | R>K | No | Ensembl | |
rs213397744 | 789 | N>T | No | Ensembl | |
rs249136693 | 793 | A>S | No | Ensembl | |
rs217253474 | 800 | T>I | No | Ensembl | |
rs27176871 | 835 | T>A | No | Ensembl | |
rs216075555 | 842 | M>T | No | Ensembl | |
rs262480590 | 906 | P>T | No | Ensembl | |
rs27176870 | 926 | T>M | No | Ensembl | |
rs241083992 | 960 | S>L | No | Ensembl | |
rs231838384 | 978 | A>S | No | Ensembl | |
rs228308702 | 1011 | P>Q | No | Ensembl | |
rs243465417 | 1095 | A>S | No | Ensembl |
No associated diseases with P00520
8 regional properties for P00520
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 242 - 493 | IPR000719 |
domain | SH2 domain | 125 - 217 | IPR000980 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 242 - 492 | IPR001245 |
domain | SH3 domain | 61 - 121 | IPR001452 |
active_site | Tyrosine-protein kinase, active site | 359 - 371 | IPR008266 |
domain | F-actin binding | 997 - 1123 | IPR015015 |
binding_site | Protein kinase, ATP binding site | 248 - 271 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 242 - 493 | IPR020635 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.2 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | PTHR24418 | TYROSINE-PROTEIN KINASE |
PANTHER Subfamily | PTHR24418:SF438 | TYROSINE-PROTEIN KINASE ABL1 |
PANTHER Protein Class | non-receptor tyrosine protein kinase | |
PANTHER Pathway Category |
Integrin signalling pathway Abl Axon guidance mediated by Slit/Robo Abl |
18 GO annotations of cellular component
Name | Definition |
---|---|
actin cytoskeleton | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. |
cell leading edge | The area of a motile cell closest to the direction of movement. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
endoplasmic reticulum | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
growth cone | The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic. |
mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
nuclear body | Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins. |
nucleolus | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
ruffle | Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork. |
synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
25 GO annotations of molecular function
Name | Definition |
---|---|
actin filament binding | Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits. |
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
bubble DNA binding | Binding to DNA segment that contains a bubble. A bubble occurs when DNA contains a region of unpaired, single-stranded DNA flanked on both sides by regions of paired, double-stranded DNA. |
delta-catenin binding | Binding to the delta subunit of the catenin complex. |
ephrin receptor binding | Binding to an ephrin receptor. |
four-way junction DNA binding | Binding to a DNA segment containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. |
kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
magnesium ion binding | Binding to a magnesium (Mg) ion. |
manganese ion binding | Binding to a manganese ion (Mn). |
mitogen-activated protein kinase binding | Binding to a mitogen-activated protein kinase. |
neuropilin binding | Binding to a member of the neuropilin family. |
non-membrane spanning protein tyrosine kinase activity | Catalysis of the reaction: ATP + protein L-tyrosine = ADP + protein L-tyrosine phosphate by a non-membrane spanning protein. |
phosphotyrosine residue binding | Binding to a phosphorylated tyrosine residue within a protein. |
proline-rich region binding | Binding to a proline-rich region, i.e. a region that contains a high proportion of proline residues, in a protein. |
protein C-terminus binding | Binding to a protein C-terminus, the end of a peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
protein domain specific binding | Binding to a specific domain of a protein. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein kinase C binding | Binding to protein kinase C. |
protein serine/threonine/tyrosine kinase activity | Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
protein tyrosine kinase activity | Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
SH2 domain binding | Binding to a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class. |
SH3 domain binding | Binding to a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. |
syntaxin binding | Binding to a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse. |
106 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
actin filament branching | The formation of daughter actin filament branches at an angle on the sides of preexisting mother filaments. |
actin filament polymerization | Assembly of actin filaments by the addition of actin monomers to a filament. |
activated T cell proliferation | The expansion of a T cell population following activation by an antigenic stimulus. |
activation of protein kinase C activity | Any process that initiates the activity of the inactive enzyme protein kinase C. |
alpha-beta T cell differentiation | The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex. |
associative learning | Learning by associating a stimulus (the cause) with a particular outcome (the effect). |
autophagy | The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. |
B cell proliferation | The expansion of a B cell population by cell division. Follows B cell activation. |
B cell proliferation involved in immune response | The expansion of a B cell population by cell division following B cell activation during an immune response. |
B cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
B-1 B cell homeostasis | The process of regulating the proliferation and elimination of B cells of the B-1 subset such that the total number of B-1 B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. B-1 B cells are a distinct subset of B cells characterized as being CD5 positive, found predominantly in the peritoneum, pleural cavities, and spleen, and enriched for self-reactivity. |
Bergmann glial cell differentiation | The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate. |
cellular response to DNA damage stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
cellular response to hydrogen peroxide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
cellular response to transforming growth factor beta stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus. |
cerebellum morphogenesis | The process in which the anatomical structure of the cerebellum is generated and organized. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. The cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills. |
circulatory system development | The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis. |
collateral sprouting | The process in which outgrowths develop from the shafts of existing axons. |
DNA conformation change | A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule. |
DNA damage induced protein phosphorylation | The widespread phosphorylation of various molecules, triggering many downstream processes, that occurs in response to the detection of DNA damage. |
DNA repair | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
endocytosis | A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. |
endothelial cell migration | The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
establishment of protein localization | The directed movement of a protein to a specific location. |
glomerular visceral epithelial cell apoptotic process | Any apoptotic process in a glomerular visceral epithelial cell. |
integrin-mediated signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to an integrin on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
learning or memory | The acquisition and processing of information and/or the storage and retrieval of this information over time. |
microspike assembly | Formation of a microspike, a dynamic, actin-rich projection extending from the surface of a migrating animal cell. |
negative regulation of BMP signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway. |
negative regulation of cell-cell adhesion | Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell. |
negative regulation of cellular senescence | Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence. |
negative regulation of endothelial cell apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process. |
negative regulation of ERK1 and ERK2 cascade | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
negative regulation of I-kappaB kinase/NF-kappaB signaling | Any process that stops, prevents, or reduces the frequency, rate or extent of -kappaB kinase/NF-kappaB signaling. |
negative regulation of long-term synaptic potentiation | Any process that stops, prevents or reduces the frequency, rate or extent of long-term synaptic potentiation. |
negative regulation of mitotic cell cycle | Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle. |
negative regulation of phospholipase C activity | Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C activity. |
negative regulation of protein serine/threonine kinase activity | Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity. |
negative regulation of ubiquitin-protein transferase activity | Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity. |
neural tube closure | The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. |
neuroepithelial cell differentiation | The process in which epiblast cells acquire specialized features of neuroepithelial cells. |
neuromuscular process controlling balance | Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors. |
neuron differentiation | The process in which a relatively unspecialized cell acquires specialized features of a neuron. |
neuropilin signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to a neuropilin protein on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
peptidyl-tyrosine autophosphorylation | The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein. |
peptidyl-tyrosine phosphorylation | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
phagocytosis | A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. |
platelet-derived growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a platelet-derived growth factor receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
platelet-derived growth factor receptor-beta signaling pathway | The series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
positive regulation of actin cytoskeleton reorganization | Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization. |
positive regulation of actin filament binding | Any process that activates or increases the frequency, rate or extent of actin filament binding. |
positive regulation of apoptotic process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
positive regulation of blood vessel branching | Any process that activates or increases the frequency, rate or extent of blood vessel branching. |
positive regulation of cell migration involved in sprouting angiogenesis | Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis. |
positive regulation of cytosolic calcium ion concentration | Any process that increases the concentration of calcium ions in the cytosol. |
positive regulation of dendrite development | Any process that activates or increases the frequency, rate or extent of dendrite development. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
positive regulation of extracellular matrix organization | Any process that activates or increases the frequency, rate or extent of extracellular matrix organization. |
positive regulation of fibroblast proliferation | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
positive regulation of focal adhesion assembly | Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions. |
positive regulation of hydrogen peroxide-mediated programmed cell death | Any process that activates or increases the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death. |
positive regulation of I-kappaB kinase/NF-kappaB signaling | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
positive regulation of interferon-gamma production | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
positive regulation of interleukin-2 production | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
positive regulation of microtubule binding | Any process that activates or increases the frequency, rate or extent of microtubule binding. |
positive regulation of mitotic cell cycle | Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. |
positive regulation of neuron apoptotic process | Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process. |
positive regulation of neuron death | Any process that activates or increases the frequency, rate or extent of neuron death. |
positive regulation of osteoblast proliferation | Any process that activates or increases the rate or extent of osteoblast proliferation. |
positive regulation of oxidoreductase activity | Any process that activates or increases the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. |
positive regulation of peptidyl-tyrosine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of release of sequestered calcium ion into cytosol | Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. |
positive regulation of stress fiber assembly | Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. |
positive regulation of substrate adhesion-dependent cell spreading | Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading. |
positive regulation of vasoconstriction | Any process that activates or increases the frequency, rate or extent of vasoconstriction. |
positive regulation of Wnt signaling pathway, planar cell polarity pathway | Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway. |
post-embryonic development | The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development. |
protein autophosphorylation | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of actin cytoskeleton organization | Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
regulation of axon extension | Any process that modulates the rate, direction or extent of axon extension. |
regulation of Cdc42 protein signal transduction | Any process that modulates the frequency, rate or extent of Cdc42 protein signal transduction. |
regulation of cell cycle | Any process that modulates the rate or extent of progression through the cell cycle. |
regulation of cell population proliferation | Any process that modulates the frequency, rate or extent of cell proliferation. |
regulation of cellular senescence | Any process that modulates the frequency, rate or extent of cellular senescence. |
regulation of extracellular matrix organization | Any process that modulates the frequency, rate or extent of extracellular matrix organization. |
regulation of microtubule polymerization | Any process that modulates the frequency, rate or extent of microtubule polymerization. |
regulation of modification of synaptic structure | Any process that modulates the frequency, rate or extent of modification of synaptic structure. |
regulation of response to DNA damage stimulus | Any process that modulates the frequency, rate or extent of response to DNA damage stimulus. |
regulation of T cell differentiation | Any process that modulates the frequency, rate or extent of T cell differentiation. |
response to endoplasmic reticulum stress | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. |
response to epinephrine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system. |
response to oxidative stress | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
signal transduction in response to DNA damage | A cascade of processes induced by the detection of DNA damage within a cell. |
spleen development | The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions. |
substrate adhesion-dependent cell spreading | The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate. |
T cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. |
thymus development | The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components. |
transitional one stage B cell differentiation | The process in which immature B cells from the bone marrow acquire the specialized features of T1 stage B cells in the spleen. T1 stage B cells do not express either CD23 or CD21. |
29 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P00522 | Abl | Tyrosine-protein kinase Abl | Drosophila melanogaster (Fruit fly) | SS |
P42684 | ABL2 | Tyrosine-protein kinase ABL2 | Homo sapiens (Human) | SS |
P00519 | ABL1 | Tyrosine-protein kinase ABL1 | Homo sapiens (Human) | EV |
P48025 | Syk | Tyrosine-protein kinase SYK | Mus musculus (Mouse) | SS |
P43404 | Zap70 | Tyrosine-protein kinase ZAP-70 | Mus musculus (Mouse) | SS |
Q64434 | Ptk6 | Protein-tyrosine kinase 6 | Mus musculus (Mouse) | SS |
P14234 | Fgr | Tyrosine-protein kinase Fgr | Mus musculus (Mouse) | SS |
P25911 | Lyn | Tyrosine-protein kinase Lyn | Mus musculus (Mouse) | EV |
P39688 | Fyn | Tyrosine-protein kinase Fyn | Mus musculus (Mouse) | SS |
P05480 | Src | Proto-oncogene tyrosine-protein kinase Src | Mus musculus (Mouse) | EV |
P06240 | Lck | Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (Mouse) | SS |
P16277 | Blk | Tyrosine-protein kinase Blk | Mus musculus (Mouse) | SS |
P08103 | Hck | Tyrosine-protein kinase HCK | Mus musculus (Mouse) | SS |
Q04736 | Yes1 | Tyrosine-protein kinase Yes | Mus musculus (Mouse) | SS |
Q922K9 | Frk | Tyrosine-protein kinase FRK | Mus musculus (Mouse) | SS |
Q03526 | Itk | Tyrosine-protein kinase ITK/TSK | Mus musculus (Mouse) | SS |
P35991 | Btk | Tyrosine-protein kinase BTK | Mus musculus (Mouse) | EV |
P24604 | Tec | Tyrosine-protein kinase Tec | Mus musculus (Mouse) | SS |
P41242 | Matk | Megakaryocyte-associated tyrosine-protein kinase | Mus musculus (Mouse) | SS |
P41241 | Csk | Tyrosine-protein kinase CSK | Mus musculus (Mouse) | EV |
Q9QVP9 | Ptk2b | Protein-tyrosine kinase 2-beta | Mus musculus (Mouse) | PR |
P34152 | Ptk2 | Focal adhesion kinase 1 | Mus musculus (Mouse) | SS |
Q99ML2 | Tnk1 | Non-receptor tyrosine-protein kinase TNK1 | Mus musculus (Mouse) | PR |
O54967 | Tnk2 | Activated CDC42 kinase 1 | Mus musculus (Mouse) | SS |
P70451 | Fer | Tyrosine-protein kinase Fer | Mus musculus (Mouse) | PR |
Q6J9G1 | Styk1 | Tyrosine-protein kinase STYK1 | Mus musculus (Mouse) | PR |
Q62270 | Srms | Tyrosine-protein kinase Srms | Mus musculus (Mouse) | SS |
Q4JIM5 | Abl2 | Tyrosine-protein kinase ABL2 | Mus musculus (Mouse) | SS |
P03949 | abl-1 | Tyrosine-protein kinase abl-1 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MLEICLKLVG | CKSKKGLSSS | SSCYLEEALQ | RPVASDFEPQ | GLSEAARWNS | KENLLAGPSE |
70 | 80 | 90 | 100 | 110 | 120 |
NDPNLFVALY | DFVASGDNTL | SITKGEKLRV | LGYNHNGEWC | EAQTKNGQGW | VPSNYITPVN |
130 | 140 | 150 | 160 | 170 | 180 |
SLEKHSWYHG | PVSRNAAEYL | LSSGINGSFL | VRESESSPGQ | RSISLRYEGR | VYHYRINTAS |
190 | 200 | 210 | 220 | 230 | 240 |
DGKLYVSSES | RFNTLAELVH | HHSTVADGLI | TTLHYPAPKR | NKPTIYGVSP | NYDKWEMERT |
250 | 260 | 270 | 280 | 290 | 300 |
DITMKHKLGG | GQYGEVYEGV | WKKYSLTVAV | KTLKEDTMEV | EEFLKEAAVM | KEIKHPNLVQ |
310 | 320 | 330 | 340 | 350 | 360 |
LLGVCTREPP | FYIITEFMTY | GNLLDYLREC | NRQEVSAVVL | LYMATQISSA | MEYLEKKNFI |
370 | 380 | 390 | 400 | 410 | 420 |
HRDLAARNCL | VGENHLVKVA | DFGLSRLMTG | DTYTAHAGAK | FPIKWTAPES | LAYNKFSIKS |
430 | 440 | 450 | 460 | 470 | 480 |
DVWAFGVLLW | EIATYGMSPY | PGIDLSQVYE | LLEKDYRMER | PEGCPEKVYE | LMRACWQWNP |
490 | 500 | 510 | 520 | 530 | 540 |
SDRPSFAEIH | QAFETMFQES | SISDEVEKEL | GKRGTRGGAG | SMLQAPELPT | KTRTCRRAAE |
550 | 560 | 570 | 580 | 590 | 600 |
QKDAPDTPEL | LHTKGLGESD | ALDSEPAVSP | LLPRKERGPP | DGSLNEDERL | LPRDRKTNLF |
610 | 620 | 630 | 640 | 650 | 660 |
SALIKKKKKM | APTPPKRSSS | FREMDGQPDR | RGASEDDSRE | LCNGPPALTS | DAAEPTKSPK |
670 | 680 | 690 | 700 | 710 | 720 |
ASNGAGVPNG | AFREPGNSGF | RSPHMWKKSS | TLTGSRLAAA | EEESGMSSSK | RFLRSCSASC |
730 | 740 | 750 | 760 | 770 | 780 |
MPHGARDTEW | RSVTLPRDLP | SAGKQFDSST | FGGHKSEKPA | LPRKRTSESR | SEQVAKSTAM |
790 | 800 | 810 | 820 | 830 | 840 |
PPPRLVKKNE | EAAEEGFKDT | ESSPGSSPPS | LTPKLLRRQV | TASPSSGLSH | KEEATKGSAS |
850 | 860 | 870 | 880 | 890 | 900 |
GMGTPATAEP | APPSNKVGLS | KASSEEMRVR | RHKHSSESPG | RDKGRLAKLK | PAPPPPPACT |
910 | 920 | 930 | 940 | 950 | 960 |
GKAGKPAQSP | SQEAGEAGGP | TKTKCTSLAM | DAVNTDPTKA | GPPGEGLRKP | VPPSVPKPQS |
970 | 980 | 990 | 1000 | 1010 | 1020 |
TAKPPGTPTS | PVSTPSTAPA | PSPLAGDQQP | SSAAFIPLIS | TRVSLRKTRQ | PPERIASGTI |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
TKGVVLDSTE | ALCLAISRNS | EQMASHSAVL | EAGKNLYTFC | VSYVDSIQQM | RNKFAFREAI |
1090 | 1100 | 1110 | 1120 | ||
NKLESNLREL | QICPATASSG | PAATQDFSKL | LSSVKEISDI | VRR |